medigraphic.com
ISSN 2007-4360 (Print)
Asociación Mexicana de Periodontología, Colegio de Periodoncistas A.C

2011, Number 1

<< Back Next >>

Rev Mex Periodontol 2011; 2 (1)

Interrelationship between diabetes, obesity

Hernández HC

Language: Spanish
References: 27
Page: 7-11
PDF size: 389.50 Kb.


ABSTRACT

Periodontitis is a chronic bacterial infection of the supporting structures of the teeth. The host response to infection is an important factor in determining the extent and severity of periodontal disease. Systemic factors modify periodontitis principally through their effects on the normal immune and inflammatory mechanisms. Several conditions may give rise to an increased prevalence, incidence or severity of gingivitis and periodontitis. The effects of a significant number of systemic diseases are unclear and often it is difficult to causally link such diseases to periodontitis. In many cases the literature is insufficient to make definite statements on links between certain systemic factors and periodontitis and for several conditions only case reports exist whereas in other areas an extensive literature is present. Periodontitis has been associated in previous literature with altered health conditions such as diabetes, obesity, cardiovascular diseases, or preterm birth. Recently, studies have suggested that periodontitis could also be associated with increased systemic inflammatory markers, dyslipidaemia, non-fasting serum glucose alterations, and endothelial dysfunction. These disturbances are part of a specific metabolic state, the so-called «metabolic syndrome».


REFERENCES

  1. Center for Disease Control and Prevention. Diabetes data & trends. Number (in millions) of persons with diagnosed diabetes, United States, 1980-2005.

  2. Available at: http://www.cdc.gov/diabetes/statistics/prev/national/figpersons.htm

  3. Center for Disease Control and Prevention. Diabetes data & trends. Overweight and obesity. U.S. Obesity Trends 1985-2006.

  4. Available at: http://www.cdc.gov/nccdphp/dnpa/obesity/trend/maps/

  5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.

  6. Soskolne WA, Klinger A. The relationship between periodontal diseases and diabetes: an overview. Ann Periodontol 2001; 6: 91-98.

  7. Singh R, Shaw J, Zimmet P. Epidemiology of childhood type 2 diabetes in the developing world. Pediatr Diabetes 2004; 5: 154-168.

  8. Center for Disease Control and Prevention. Diabetes data & trends. National diabetes fact sheet. United States, 2005 General Information.

  9. Available at: http://apps.nccd.cdc.gov/DDTSTRS/template/ndfs_2005.pdf

  10. Mooradian AD. Obesity: a rational target for managing diabetes mellitus. Growth Horm IGF Res 2001; 11 (Suppl. A): S79-S83.

  11. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.

  12. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.

  13. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002; 30: 182-192.

  14. Al-Zahrani MS, Bissada NF, Borawski EA. Obesity and periodontal disease in young, middle-aged, and older adults. J Periodontol 2003; 74: 610-615.

  15. Genco R, Grossi S, Ho A, Nishimura F, Murayama Y. A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol 2005; 76: 2075-2084.

  16. Ritchie C. Obesity and periodontal disease. Periodontology 2000 2007; 44: 154-163.

  17. Saito T, Shimazaki Y. Metabolic disorders related to obesity and periodontal disease. Periodontology 2000 2007; 43: 254-266.

  18. Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997; 96: 3248-3250.

  19. Pearson TA, Mensah GA, Alexander R, Vinicor F. Centers for Disease Control Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.

  20. Baumann H, Gauldie J. The acute phase response. Immunology Today 1994; 15: 74-80.

  21. D’Aituo F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, Toneiit MS. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004; 83: 156-160.

  22. Loos BG, Craandiji J, Hoek FJ, Wertheim-van Dillen PME, van der Velden U. C-reactive protein and other markers of systemic inflammation in relation to cardiovascular diseases are elevated in periodontitis. J Periodontol 2000; 71: 1528-1543.

  23. Collin HL, Uusitupa M, Niskanen L, Kontturi-Närhi V, Markkanen H, Koivisto AM, Meurman JH. Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontal 1998; 69: 962-966.

  24. Grossi SG. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol 2001; 6: 138-145.

  25. Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata K, Makino H, Fukuda T, Tsuji T, Iwamoto M, Murayama Y. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001; 72: 774-778.

  26. Stewart JE, Wager KA, Friedlander AH, Zadeh HH. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol 2001; 28: 306-310.

  27. Saito T, Shimazaki Y, Kiyocara Y, Kato I, Kubo M, Iida M, Koga T. The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study. J Dent Res 2004; 83: 485-490.




2020     |     www.medigraphic.com